Casirivimab (REGN10933) is a human monoclonal antibody that targets the SARS-CoV-2 virus, which causes COVID-19. Casirivimab is ineffective against COVID-19 variants. Casirivimab can be used in combination with Imdevimab (HY-P99342), which alters the lung response of K18-hACE2 mice to the SARS-CoV-2 delta variant, effectively reducing viral load and improving symptoms[1][2].
Molekulargewicht:
(145.24 kDa)
Reinheit:
99.54
CAS Nummer:
[2415933-42-3]
Target-Kategorie:
SARS-CoV
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten